|
|
||||||||
1 Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224; and 2 Division of Molecular Cardiology, The Cardiovascular Research Institute, The Texas A & M University System Health Science Center, Temple, Texas 76504
| |
ABSTRACT |
|---|
|
|
|---|
The intracardiac ANG II-forming pathway
is activated in the senescent myocardium, raising the possibility of
enhanced ANG II effects on cardiac fibroblasts. This study established
an in vitro model of cultured cardiac fibroblasts from aged rats to examine if the response of these cells to ANG II is modified in the
aged heart. Levels of mRNA encoding renin, angiotensinogen, and the
AT1 receptor subtype in cardiac fibroblasts from young adult and senescent rats were quantified by RT-PCR, net collagen production by a hydroxyproline-based assay, and transforming growth factor (TGF)-
levels using a commercial kit. In cardiac fibroblasts from young adult rats, ANG II significantly enhanced AT1
mRNA levels, net collagen production, and TGF-
production. In
fibroblasts from the aged myocardium, ANG II downregulated
AT1 mRNA expression, had a less pronounced effect on net
collagen production, and had no effect on TGF-
production. Such
age-related modification of the response of cardiac fibroblasts to ANG
II may counteract the effects of augmented intracardiac ANG II
production in the senescent heart, limiting fibrogenesis.
renin-angiotensin system; transforming growth factor-
; angiotensin type 1 receptor; collagen; cardiac fibrosis
| |
INTRODUCTION |
|---|
|
|
|---|
ANG II exerts a wide range of cardiovascular effects that have a bearing on the pathophysiology of cardiac hypertrophy and heart failure (17, 19, 29, 38, 42). The efficacy of angiotensin-converting enzyme (ACE) inhibitors and angiotensin type 1 (AT1) receptor antagonists in blocking cardiac hypertrophy and remodeling suggests that ANG II may be an important trophic factor in the heart (1, 13, 20, 33). Several studies have shown that ANG II promotes myocyte hypertrophy, increases myocardial collagen synthesis, and is mitogenic to neonatal cardiac fibroblasts (6, 35, 36, 43). Identification of the components of the renin-angiotensin system (RAS), including angiotensin receptors, in cardiac tissue suggests the existence of an autocrine/paracrine system that can act independently of circulating ANG II (7). Increased gene transcript levels of the components of RAS, including renin, angiotensinogen, angiotensin receptors, and ACE, have been reported in many pathophysiological conditions (18, 24, 25, 30, 32, 37, 38, 40). Moreover, a growing body of evidence also suggests that locally produced ANG II can elicit functional responses in the heart (7, 29). In particular, studies on RAS expression in different cell types within the myocardium support a role for intracardiac RAS in the pathophysiology of cardiac remodeling (10, 15, 27).
During aging, circulating RAS activity is depressed (16), but the ventricular myocardium is associated with elevated angiotensinogen, ACE, AT1, and angiotensin type 2 (AT2) receptor gene expression and higher density of AT1 and AT2 binding (15, 16). Freshly isolated cardiac myocytes of aged rats were also found to express increased levels of ANG II type 1 and type 2 mRNA compared with cardiomyocytes from young adult rats (15). Cardiac fibroblasts, which account for nearly 90% of the nonmyocyte population of the heart, express the components of RAS (10, 27). Because fibroblasts are the primary site of collagen production and the stimulatory effect of ANG II on collagen synthesis is well documented, increased intracardiac RAS activity in the aged heart raises the possibility of increased paracrine effects of ANG II on these cells. Surprisingly, however, there is a decline in collagen synthesis per se in the aged heart, as shown by significant reductions in collagen type I and type III mRNA levels (2) and [3H]proline incorporation into collagen (28). The reduction in collagen synthesis in the senescent myocardium points to age-associated metabolic changes in cardiac fibroblasts. In an attempt to define senescence-associated alterations in cardiac fibroblast activity, the present study tested the hypothesis that the response of these cells to ANG II is modified in the aged myocardium.
The specific objectives of this investigation were twofold:
1) to develop an in vitro model of cultured cardiac
fibroblasts from aged rats that could be used to determine whether ANG
II influences expression of renin, angiotensinogen, and the
AT1 receptor mRNA in cardiac fibroblasts from young adult
and old rats and 2) to compare the effects of ANG II on
production of collagen and transforming growth factor-
(TGF-
) in
fibroblasts from young adult and aged rat heart.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Isolation of cardiac fibroblasts from senescent rats. Cardiac fibroblasts from male Wistar rats (young, 2-3 mo; old, 24 mo) were isolated by enzymatic digestion of ventricular tissue, as described earlier (39). Briefly, the heart was excised, minced, and washed in PBS. The tissue was digested at 37°C in digestion medium containing a mixture of collagenase B [115 (young) or 150 (old) mg/100 ml; Boehringer-Mannheim], trypsin (50 mg/100 ml; Sigma Chemical, St. Louis, MO), and pancreatin (60 mg/100 ml; Sigma Chemical) for 10 min with constant shaking. Cells from fourth to tenth digestions, each of 10 min duration, were pelleted and plated on 35-mm plates in medium consisting of DMEM, medium-199, and FCS at 7:2:1. After incubation at 37°C in a CO2 incubator for 150 min, unattached cells were discarded, and attached cells (mostly fibroblasts) were washed and grown in the plating medium. Confluent cultures were passaged three or four times on 100-mm dishes using trypsin.
The fibroblastic nature of the cells was ascertained by immunocytochemistry using polyclonal anti-factor VIII (Dako), monoclonal anti-desmin (Sigma Chemical), and polyclonal anti-vimentin (Polysciences) antibodies for identification of endothelial cells, smooth muscle cells, and fibroblasts, respectively (43). A streptavidin alkaline phosphatase-based protocol with Vector Red (Vector Laboratories, Burlingame, CA) as a chromogen was used.Isolation of RNA and quantification of renin, angiotensinogen,
and AT1A/B receptor mRNA.
Confluent cultures were serum deprived for 24 h and incubated in
serum-free medium for another 24 h with 100 nM ANG II. The ANG II
was replenished after 12 h. Total RNA was extracted as described
by Chirgwin et al. (5) using guanidinium isothiocyanate. Absolute amounts of renin, angiotensinogen, and AT1A/B mRNA
in RNA samples were determined using a multiplex RT-PCR titration assay, as described elsewhere (9). Fixed amounts of total
RNA (250 ng/tube) were coreverse transcribed with 2:1 serial dilutions of angiotensinogen (100-1.563 fg), renin (12.5-0.195 fg),
AT1A/B (762-11.91 fg), and elongation factor-1 (EF-1;
125-1.95 pg) competitor RNA. Coamplification was performed
using Taq polymerase (2.5 U/reaction) for 15 cycles with
angiotensinogen and renin primers (100 pmol each) or 12 cycles with
AT1A/B primers (100 pmol), after which EF-1
primers (100 pmol) were added to the reaction, and a total of 35 amplification
cycles was performed. The PCR products were separated by
electrophoresis on 6% polyacrylamide gels, after which gels were
stained for 45 min with Vistra Green (diluted 1:10,000). Intensities of
PCR bands were quantified by fluorescent scanning (Storm 640; Molecular
Dynamics, Sunnyvale, CA). Amounts of target mRNA in samples were
determined as previously described (8).
Measurement of TGF-
levels in the medium.
Confluent cultures were serum deprived for 24 h and incubated in
serum-free medium for another 24 h with 100 nM ANG II. TGF-
levels in the medium were measured by a quantitative sandwich enzyme
immunoassay technique, using commercial kits (R&D Systems) and the
manufacturer's protocol.
Measurement of net collagen production. Confluent cultures were serum deprived for 24 h and incubated in serum-free medium for another 24 h with 100 nM ANG II. Net collagen production (present in cell monolayer and medium) was determined by a hydroxyproline-based assay, as described previously (43).
Statistical analysis. All data are expressed as means ± SD. To evaluate effects of ANG II on young and old rats, pairwise comparisons were made by Student's t-test, and significance was determined at P < 0.05. Data were also analyzed by two-way ANOVA with age, drug, and age × drug interaction terms, and P < 0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Highly enriched cultures of cardiac fibroblasts were prepared from
2- to 3-mo-old or 24-mo-old rats by passaging three or four times the
cells that adhered to the culture dish during the preplating procedure
after isolation. Cardiac myocytes were ruled out on morphological
grounds. The cultures were negative for factor VIII and desmin, ruling
out contaminating endothelial cells and smooth muscle cells. The cells
formed a monolayer, had typical rat cardiac fibroblast morphology, and
stained positive for vimentin, confirming their fibroblastic nature
(=99% purity). Importantly, cultures (young and old) took about the
same time to become confluent so that the cells from both age groups
remained in culture for the same number of days at each passage. This
precluded any influence of age-related differences in time to
confluence on cellular metabolism and response to stimuli. To compare
the profibrogenic effects of ANG II on fibroblasts from young adult and
old rats, cultures at passage three or four were used to evaluate
direct transcriptional control of ANG II over renin, angiotensinogen,
and the AT1 receptor. Quantitative RT-PCR was employed to
measure transcript levels with precision. Figure
1A shows
the separation of multiplex PCR products for the AT1A/B
receptor. Effects of ANG II on TGF-
production and net collagen
production were also assessed.
|
Dostal et al. (10, 11) had demonstrated that cardiac fibroblasts from neonatal rats express renin mRNA. This study extends their observation and shows that cardiac fibroblasts from adult rats (both young and old) also express the transcript for renin. ANG II, at 100 nM, did not have any effect on renin or angiotensinogen mRNA levels in either young or old rats (Fig. 1, B and C). However, ANG II exerted differential effects on AT1 mRNA expression in young and old rats (Fig. 1D), inducing a nearly twofold increase in young rats (P < 0.01) and a 2.5-fold decrease in old rats (P < 0.001).
ANG II has been shown to increase TGF-
mRNA levels and bioactivity
in neonatal and adult rat cardiac fibroblasts (14, 22). In
the present study, experiments were carried out to compare the effects
of ANG II on TGF-
production in young and old rats. ANG II, at 100 nM, caused a more than fourfold increase in TGF-
production in young
rats (P < 0.001). However, ANG II had no effect on
TGF-
production in old rats (Fig. 2).
|
Because cardiac fibroblasts are the main source of collagens, the
effect of ANG II on net collagen production (collagen deposition) was
determined. The cell monolayer and medium were pooled and used for
determination of collagen-associated hydroxyproline content. Results
presented in Fig. 3 show that ANG II
significantly enhanced net collagen production in young
(P < 0.001) and old (P < 0.01) rats,
but the extent of stimulation in old rats was only 14.2% compared with
the 31% increase in young rats. Analysis using two-way ANOVA indicates
that the age × ANG II interaction was significant for
AT1 mRNA expression and TGF-
(P < 0.001) but not net collagen production.
|
| |
DISCUSSION |
|---|
|
|
|---|
The presence of RAS components in cardiac fibroblasts, ANG II-induced hyperplasia of neonatal rat cardiac fibroblasts, and stimulation of AT1 receptors resulting in increased gene expression for extracellular matrix proteins in adult rat cardiac fibroblasts suggest a role for RAS in regulating cardiac fibroblast activity. However, information regarding regulation of RAS in cardiac fibroblasts is sparse. Atrial natriuretic peptide and isoproterenol are reported to be positive regulators of renin and/or angiotensinogen mRNA expression in neonatal cardiac fibroblasts (11, 23). Negative feedback regulation of renin and angiotensinogen expression by ANG II in neonatal cardiac fibroblasts (11), in contrast to upregulation of these transcripts by ANG II in cardiac myocytes (27), would point to cell-specific differences in the regulation of RAS components within the myocardium. Given the marked alterations in cardiac structure and morphology associated with aging, and the role of fibroblasts in myocardial remodeling, it would be reasonable to expect changes in the regulation of RAS activity in cardiac fibroblasts from the senescent myocardium.
The present study has for the first time developed a model of cultured cardiac fibroblasts isolated from aged rats to examine senescence-associated changes in the expression of profibrogenic factors in response to ANG II. The use of such a model permitted evaluation of age-associated changes in cellular responses to ANG II in the absence of complicating systemic effects such as hemodynamic stress.
The present findings demonstrate, for the first time, that cardiac fibroblasts from senescent rats express the transcripts for renin, angiotensinogen, and the AT1 receptor. Previously, expression of renin mRNA has been demonstrated in neonatal rat cardiac fibroblasts (11) but not cardiac fibroblasts from adult rats. The question of the cardiac origin of renin is not settled yet. Literature on the subject indicates that both renin uptake from the plasma and local renin synthesis may be important (12). The relative contributions of uptake vs. local synthesis of renin and the factors that regulate these processes remain to be evaluated. This study examined the possibility that ANG II may regulate RAS component expression in cardiac fibroblasts (Fig. 1, B-D). This is particularly relevant in old rats, since the intracardiac ANG II-forming pathway has been reported to be activated in the senescent myocardium (16), raising the possibility of enhanced ANG II effects on fibroblasts. It was observed that ANG II does not have any effect on the expression of angiotensinogen or renin in either young or old rats. It has been reported that ANG II does not have any appreciable effect in vitro on the expression of angiotensinogen, renin, and ACE genes but significantly downregulates AT1 expression in neonatal rat cardiac fibroblasts (27). In the present study, ANG II caused a significant upregulation of AT1 mRNA expression in young rats but downregulated AT1 expression in old rats (Fig. 1D). Although the expression of AT1 receptor was determined only at the mRNA level, the differential effect of ANG II was striking. The effect of ANG II on AT2 expression in cardiac fibroblasts was not assessed in the present study. Although there are two major ANG II receptor subtypes, AT1 and AT2, traditional ANG II effects are attributed to AT1, and the precise role of AT2 is unclear (3, 31).
ANG II was found to stimulate TGF-
production in young rats, whereas
TGF-
production in old rats remained unaffected in response to ANG
II (Fig. 2). Another significant finding was that the stimulatory
effect of ANG II on net collagen production is less marked in old
compared with young rats (Fig. 3). Besides its stimulatory effect on
collagen synthesis, ANG II has been shown to inhibit collagenase
activity in cultured adult rat cardiac fibroblasts (4).
Because net collagen production is related to turnover, the relative
contributions of synthesis and degradation to the observed ANG II
effects in young and old rats remain to be determined.
The downregulation of AT1 expression and the lack of an
effect on TGF-
production in old rats in response to ANG II may have important implications in relation to the extent of fibrosis in the
aged myocardium. It is recognized that ANG II acts via the AT1 receptor to stimulate collagen synthesis in adult
cardiac fibroblasts (6, 43). Furthermore, it has been
suggested that TGF-
may mediate the stimulatory effect of ANG II on
collagen synthesis (22). In light of these observations,
increased production of ANG II in the senescent heart (16)
would be expected to exert stimulatory paracrine effects on collagen
synthesis in fibroblasts. However, contrary to expectation, collagen
synthesis per se has been shown to be depressed in the aged heart
(2, 28), in which reduced expression and activity of
matrix metalloproteinases are suggested to contribute to myocardial
fibrosis (34). Findings of the present study raise the
possibility that downregulation of AT1 expression by ANG II
and lack of a stimulatory effect of ANG II on TGF-
production in old
rats may blunt the effect of augmented local production of ANG II on
net collagen formation, thereby limiting the extent of ANG II-mediated
fibrosis in the aged heart. The postulation is consistent with the less
marked stimulatory effect of ANG II on net collagen production in old compared with young rats (Fig. 3). Importantly, such a mechanism would
be protective, since increasing myocardial fibrosis is an important
cause of contractile dysfunction and arrhythmias during aging
(21). It is also interesting because several
age-associated changes, such as the decline in sarcoplasmic reticulum
Ca2+-ATPase activity (26) and diminished
capacity of the heart to undergo compensatory hypertrophy in response
to hemodynamic overload (41), have adverse effects and
contribute to higher incidence of heart failure in the aged.
In summary, a new model has been set up to study alterations in the
expression of profibrogenic factors in cardiac fibroblasts from the
aged myocardium in the absence of systemic effects. The findings reveal
significant modification of the response of old rats to ANG II. The
downregulation of AT1 by ANG II, the inability of ANG II to
enhance TGF-
production, and attenuation of the stimulatory effect
of ANG II on net collagen production in cardiac fibroblasts from the
aged rat may represent a compensatory mechanism to limit fibrogenesis
in the context of increased local production of ANG II in the aged heart.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Bruce Ziman, Jennifer Griffin, and Manuela Smith for excellent technical assistance and Dr. Sankar Sarma for help with statistical evaluation of the data.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant HL-44883 and National American Heart Association Grant 0050421. The Department of Biotechnology, Government of India, also provided financial support.
Address for reprint requests and other correspondence: K. Shivakumar, Div. of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 695 011, India (E-mail: shivak{at}sctimst.ker.nic.in).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published December 19, 2002;10.1152/ajpheart.00766.2002
Received 4 September 2002; accepted in final form 10 December 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Baker, KM,
Chernin MI,
Wixson SK,
and
Aceto JF.
Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.
Am J Physiol Heart Circ Physiol
259:
H324-H332,
1990
2.
Besse, S,
Robert V,
Assayag P,
Declayre C,
and
Swynghedauw B.
Non-synchronous changes in myocardial collagen mRNA and protein during aging: effect of DOCA salt hypertension.
Am J Physiol Heart Circ Physiol
267:
H2237-H2244,
1994
3.
Brede, M,
Hadamek K,
Meinel L,
Wiesmann F,
Peters J,
Engelhardt S,
Simm A,
Haase A,
Lohse MJ,
and
Hein L.
Vascular hypertrophy and increased P70S6 kinase in mice lacking the AII AT2 receptor.
Circulation
104:
2602-2607,
2001
4.
Brilla, CG,
Zhou G,
Matsubara LS,
and
Weber KT.
Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
J Mol Cell Cardiol
26:
808-820,
1994.
5.
Chirgwin, JM,
Przybyla AE,
MacDonald RJ,
and
Rutter WJ.
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
Biochemistry
18:
5294-5299,
1979[Medline].
6.
Crabos, M,
Roth MM,
Hahn AWA,
and
Erne P.
Characterization of angiotensin II in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression.
J Clin Invest
93:
2372-2378,
1994[ISI][Medline].
7.
Dostal, DE,
and
Baker KM.
The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?
Circ Res
85:
643-650,
1999
8.
Dostal, DE,
Kempinski AM,
Motel TJ,
and
Baker KM.
Absolute quantification of messenger RNA using multiplex reverse transcriptase polymerase reaction.
In: RT-PCR Methods for Gene Cloning and Analysis, edited by Siebert PD,
and McAndrews C.. Natick, MA: Eaton, 1998, p. 71-90.
9.
Dostal, DE,
Rothblum KN,
and
Baker KM.
An improved method for absolute quantification of mRNA using multiplex polymerase chain reaction: determination of renin and angiotensinogen mRNA levels in various tissues.
Anal Biochem
223:
239-249,
1994[ISI][Medline].
10.
Dostal, DE,
Rothblum KN,
Conrad KM,
Cooper GR,
and
Baker KM.
Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts.
Am J Physiol Cell Physiol
263:
C851-C863,
1992
11.
Dostal, DE,
Rothblum KC,
Lin CC,
and
Baker KM.
Regulation of renin and angiotensinogen in cultured neonatal rat cardiac fibroblasts by adrenergic, glucocorticoids, and angiotensin II stimulation (Abstract).
Hypertension
26:
A562,
1995.
12.
Dzau, VJ.
Tissue angiotensin system in cardiovascular medicine. A paradigm shift?
Circulation
89:
493-498,
1994
13.
Everett, AD,
Tufro-McReddie A,
Fisher A,
and
Gometz A.
Angiotensin receptor regulates cardiac hypertrophy and TGF-
1 expression.
Hypertension
23:
587-592,
1994
14.
Fisher, SA,
and
Absher M.
Norepinephrine and angiotensin II stimulate secretion of TGF-
by neonatal rat cardiac fibroblasts in vitro.
Am J Physiol Cell Physiol
268:
C910-C917,
1995
15.
Heymes, C,
Silvestre JS,
Cortes CL,
Chevalier B,
Marotte F,
Levy B,
Swynghedauw B,
and
Samuel JL.
Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes.
Endocrinology
139:
2579-2587,
1998
16.
Heymes, C,
Swynghedauw B,
and
Chevalier B.
Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats.
Circulation
90:
1328-1333,
1994
17.
Higaki, J,
Aoki M,
Morishita R,
Kida I,
Taniyama Y,
Tomita N,
Yamamoto K,
Moriguchi A,
Kaneda Y,
and
Ogihara T.
In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy.
J Arterioscler Thromb Vasc Biol
20:
428-434,
2000.
18.
Hirsch, AT,
Talsness CE,
Schunkert H,
Paul M,
and
Dzau VJ.
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.
Circ Res
69:
475-482,
1991
19.
Ihara, M,
Urata H,
Shirai K,
Ideishi M,
Hoshino F,
Suzumiya J,
Kikuchi M,
and
Arakawa K.
High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium.
Cardiology
94:
247-253,
2000[ISI][Medline].
20.
Jin, H,
Yang R,
Awad TA,
Wang F,
Li W,
Williams SP,
Ogasawa A,
Shimada B,
Williams M,
De Feo G,
and
Pioni NF.
Effects of early angiotensin converting enzyme inhibition on cardiac gene expression after acute myocardial infarction.
Circulation
103:
736-742,
2001
21.
Lakatta, EG.
Cardiovascular regulatory mechanisms in advanced age.
Physiol Rev
73:
413-467,
1993
22.
Lee, AA,
Dillmann WH,
McCulloch AD,
and
Villarreal FJ.
Angiotensin II stimulates the autocrine production of transforming growth factor-
1 in adult rat cardiac fibroblasts.
J Mol Cell Cardiol
27:
2347-2357,
1995[ISI][Medline].
23.
Lin, CL,
Baker KM,
Rothblum KC,
Booz GW,
and
Dostal DE.
Atrial natriuretic peptide regulation of renin and angiotensinogen mRNA in cultured neonatal rat ventricular cardiac fibroblasts (Abstract).
Hypertension
26:
A563,
1995.
24.
Lindpaintner, K,
and
Ganten D.
The cardiac renin-angiotensin system: an appraisal of present experimental and clinical evidence.
Circ Res
68:
905-921,
1991
25.
Lindpaintner, K,
Wenyan L,
Niedermajer N,
Schieffer B,
Just H,
Ganten D,
and
Drexler H.
Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat.
J Mol Cell Cardiol
25:
133-143,
1993[ISI][Medline].
26.
Maciel, LMZ,
Polikar R,
Rohrer D,
Popovich BK,
and
Dillmann WH.
Age-induced decreases in the messenger RNA coding for the sarcoplasmic reticulum Ca-ATPase of the rat heart.
Circ Res
67:
230-234,
1990
27.
Malhotra, R,
Sadoshima J,
Brosius FC, III,
and
Izumo S.
Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro.
Circ Res
85:
137-146,
1999
28.
Mays, PK,
McAnulty RJ,
Campa JS,
and
Laurent GJ.
Age-related changes in collagen synthesis and degradation in rat tissues.
Biochem J
276:
307-313,
1991[ISI][Medline].
29.
Mazzolai, L,
Pedrazzini T,
Nicoud F,
Gabbiani G,
Brunner HR,
and
Nussberger J.
Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice.
J Hypertens
35:
985-991,
2000.
30.
Nio, Y,
Matsubara H,
Murasawa H,
Kanasaki M,
and
Inada M.
Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
J Clin Invest
95:
46-54,
1995[ISI][Medline].
31.
Opie, LH,
and
Sack MN.
Enhanced angiotensin II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptor subtype.
Circ Res
88:
654-658,
2001
32.
Passier, RC,
Smits JF,
Verluyten MJ,
and
Daenen MJ.
Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction.
Am J Physiol Heart Circ Physiol
271:
H1040-H1048,
1996
33.
Pfeffer, JM,
Pfeffer MA,
Mirsky I,
and
Braunwald E.
Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in spontaneously hypertensive rats.
Proc Natl Acad Sci USA
79:
3310-3314,
1982
34.
Robert, V,
Besse S,
Sabri A,
Silvestre JS,
Assayag P,
Thiem NV,
Swynghedauw B,
and
Declayre C.
Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart.
Lab Invest
76:
729-738,
1997[ISI][Medline].
35.
Sadoshima, J,
and
Izumo S.
Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype.
Circ Res
73:
413-423,
1993
36.
Schorb, W,
Booz W,
Dostal DE,
Conrad KM,
Chang KC,
and
Baker KM.
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts.
Circ Res
72:
1245-1254,
1993
37.
Schunkert, H,
Dzau VJ,
Than SS,
Hirsch AT,
Apstein CS,
and
Lorell BH.
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure-overload left ventricular hypertrophy.
J Clin Invest
86:
1913-1920,
1990[ISI][Medline].
38.
Serneri, GG,
Boddi M,
Cecioni I,
Vanni S,
Coppo M,
Papa ML,
Bandinelli B,
Bertolozzi I,
Polidori G,
Toscano T,
Maccherini M,
and
Modesti PA.
Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function.
Circ Res
88:
961-968,
2001
39.
Shivakumar, K,
and
Kumaran C.
L-type calcium channel blockers and EGTA enhance superoxide production in cardiac fibroblasts.
J Mol Cell Cardiol
33:
373-377,
2001[ISI][Medline].
40.
Suzuki, J,
Matsubara H,
Urakami M,
and
Inada M.
Rat angiotensin II (type IA) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy.
Circ Res
73:
439-447,
1993
41.
Takahashi, T,
Schunkert H,
Isoyama S,
Wei JY,
Ginard BN,
Grossman W,
and
Izumo S.
Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium.
J Clin Invest
89:
939-946,
1992[ISI][Medline].
42.
Van Kats, JP,
Danser AH,
van Meegen JR,
Sassen LM,
Verdouw PD,
and
Schalekamp MA.
Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions.
Circulation
98:
73-81,
1998
43.
Villarreal, FJ,
Kim NN,
Ungab GD,
Printz MP,
and
Dillmann WH.
Identification of functional angiotensin II receptors on rat cardiac fibroblasts.
Circulation
88:
2849-2861,
1993
This article has been cited by other articles:
![]() |
M. Bujak, H. J. Kweon, K. Chatila, N. Li, G. Taffet, and N. G. Frangogiannis Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial Infarction J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1384 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, Z. Li, Z. Feng, J. Wang, C. Ouyang, W. Liu, B. Fu, G. Cai, C. Wu, R. Wei, et al. Integrin-Linked Kinase Induces Both Senescence-Associated Alterations and Extracellular Fibronectin Assembly in Aging Cardiac Fibroblasts J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1232 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, D. Zhao, G. Spinetti, J. Zhang, L.-Q. Jiang, G. Pintus, R. Monticone, and E. G. Lakatta Matrix Metalloproteinase 2 Activation of Transforming Growth Factor-{beta}1 (TGF-{beta}1) and TGF-{beta}1-Type II Receptor Signaling Within the Aged Arterial Wall Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1503 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sapna, S. K. Ranjith, and K. Shivakumar Cardiac fibrogenesis in magnesium deficiency: a role for circulating angiotensin II and aldosterone Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H436 - H440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, H. Chen, A. Seth, and C. A. McCulloch Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1871 - H1881. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |